Jazz Pharmaceuticals Plc (JAZZ)
229.70
+0.94
(+0.41%)
USD |
NASDAQ |
May 18, 16:00
227.00
-2.70
(-1.18%)
After-Hours: 16:58
Jazz Pharmaceuticals EPS Diluted (Quarterly) : 4.434 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perrigo Co. Plc | -2.874 |
| Merck & Co., Inc. | -1.715 |
| Axsome Therapeutics, Inc. | -1.261 |
| Bristol Myers Squibb Co. | 1.308 |
| Avadel Pharmaceuticals Plc | 0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 293.10M |
| Revenue (Quarterly) | 1.069B |
| Total Expenses (Quarterly) | 775.80M |
| Enterprise Value | 16.90B |
| Gross Profit Margin (Quarterly) | 71.34% |
| Profit Margin (Quarterly) | 27.42% |
| Earnings Yield | -0.01% |
| Operating Earnings Yield | 5.86% |
| Normalized Earnings Yield | 5.036 |